ResMed Inc (RSMDF) stock
RSMDFOTCSurgical & Medical Instruments & ApparatusFiscal year ends June 30Also trades as RMD
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Aug 13, 2026Score 21/3011% below fair value
$22.61+0.00 (0.00%)
Close on Oct 19, 2026Market cap $33.17BP/E 22.0Yield 1.04%
ResMed r&d expenses
Research and development expenses are spending on new products and technology.
ResMed's R&D Expenses for the twelve months ending Jun 30, 2026 was $378.29M, up 14.2% year over year. For fiscal 2026 it was $378.29M, up 14.2% from the year before. Over ten years it grew 12.3% a year on average. The highest annual figure on record is $378.29M in fiscal 2026.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $378.29M | +14.2% |
| FY2025 | Jun 30, 2025 | $331.28M | +7.7% |
| FY2024 | Jun 30, 2024 | $307.53M | +6.9% |
| FY2023 | Jun 30, 2023 | $287.64M | +13.4% |
| FY2022 | Jun 30, 2022 | $253.58M | +12.6% |
| FY2021 | Jun 30, 2021 | $225.28M | +11.6% |
| FY2020 | Jun 30, 2020 | $201.95M | +11.8% |
| FY2019 | Jun 30, 2019 | $180.65M | +16.4% |
| FY2018 | Jun 30, 2018 | $155.15M | +7.4% |
| FY2017 | Jun 30, 2017 | $144.47M | +21.8% |
| FY2016 | Jun 30, 2016 | $118.65M | +3.3% |
| FY2015 | Jun 30, 2015 | $114.87M | -2.8% |
| FY2014 | Jun 30, 2014 | $118.23M | -1.6% |
| FY2013 | Jun 30, 2013 | $120.12M | +9.5% |
| FY2012 | Jun 30, 2012 | $109.73M | +19.3% |
| FY2011 | Jun 30, 2011 | $92.01M | +22.3% |
| FY2010 | Jun 30, 2010 | $75.20M | +19.3% |
| FY2009 | Jun 30, 2009 | $63.06M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026 | Jun 30, 2026 | $105.73M | +22.3% |
| Q3 FY2026 | Mar 31, 2026 | $94.27M | +12.3% |
| Q2 FY2026 | Dec 31, 2025 | $90.97M | +11.8% |
| Q1 FY2026 | Sep 30, 2025 | $87.32M | +9.8% |
| Q4 FY2025 | Jun 30, 2025 | $86.44M | +6.9% |
| Q3 FY2025 | Mar 31, 2025 | $83.94M | +8.9% |
| Q2 FY2025 | Dec 31, 2024 | $81.37M | +10.1% |
| Q1 FY2025 | Sep 30, 2024 | $79.52M | +5.0% |
| Q4 FY2024 | Jun 30, 2024 | $80.86M | +3.5% |
| Q3 FY2024 | Mar 31, 2024 | $77.07M | +0.8% |
| Q2 FY2024 | Dec 31, 2023 | $73.88M | +5.7% |
| Q1 FY2024 | Sep 30, 2023 | $75.71M | +19.8% |
| Q4 FY2023 | Jun 30, 2023 | $78.14M | +21.5% |
| Q3 FY2023 | Mar 31, 2023 | $76.44M | +14.4% |
| Q2 FY2023 | Dec 31, 2022 | $69.87M | +11.8% |
| Q1 FY2023 | Sep 30, 2022 | $63.19M | +5.4% |
| Q4 FY2022 | Jun 30, 2022 | $64.32M | +7.4% |
| Q3 FY2022 | Mar 31, 2022 | $66.80M | +19.4% |
| Q2 FY2022 | Dec 31, 2021 | $62.51M | +13.8% |
| Q1 FY2022 | Sep 30, 2021 | $59.95M | +9.9% |
| Q4 FY2021 | Jun 30, 2021 | $59.88M | +14.0% |
| Q3 FY2021 | Mar 31, 2021 | $55.94M | +8.7% |
| Q2 FY2021 | Dec 31, 2020 | $54.94M | +10.0% |
| Q1 FY2021 | Sep 30, 2020 | $54.53M | +13.5% |
| Q4 FY2020 | Jun 30, 2020 | $52.52M | +2.7% |
| Q3 FY2020 | Mar 31, 2020 | $51.45M | +8.1% |
| Q2 FY2020 | Dec 31, 2019 | $49.94M | +15.8% |
| Q1 FY2020 | Sep 30, 2019 | $48.03M | +23.8% |
| Q4 FY2019 | Jun 30, 2019 | $51.14M | +29.0% |
| Q3 FY2019 | Mar 31, 2019 | $47.61M | +27.2% |
| Q2 FY2019 | Dec 31, 2018 | $43.11M | +6.1% |
| Q1 FY2019 | Sep 30, 2018 | $38.79M | +3.7% |
| Q4 FY2018 | Jun 30, 2018 | $39.66M | +8.0% |
| Q3 FY2018 | Mar 31, 2018 | $37.43M | +6.6% |
| Q2 FY2018 | Dec 31, 2017 | $40.64M | +6.4% |
| Q1 FY2018 | Sep 30, 2017 | $37.42M | +8.6% |
| Q4 FY2017 | Jun 30, 2017 | $36.71M | – |
| Q3 FY2017 | Mar 31, 2017 | $35.13M | – |
| Q2 FY2017 | Dec 31, 2016 | $38.19M | – |
| Q1 FY2017 | Sep 30, 2016 | $34.45M | – |